Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: Ductal carcinoma in situ vs. invasive ductal carcinoma

European Journal of Radiology

Volumn 83, Issue 8, 2014, Pages 1363-1367

  Nadrljanski, Mirjan ^a   Maksimović, Ružica ^b,c   Plešinac Karapandžić, Vesna ^a,c   Nikitović, Marina ^a,c   Marković Vasiljković, Biljana ^b,c   Milošević, Zorica ^a,c  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Breast; Breast neoplasms; Carcinoma; Ductal; Intraductal; Invasive; Magnetic resonance imaging; Noninfiltrating

Indexed keywords

ADULT; ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIGITAL MAMMOGRAPHY; ECHOMAMMOGRAPHY; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; ONCOLOGICAL PARAMETERS; POSITIVE ENHANCEMENT INTEGRAL VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOLOGICAL PARAMETERS; STANDARDIZATION; STATISTICAL SIGNIFICANCE; TUMOR TO NON TUMOR RATIO; TUMOR VOLUME; BREAST TUMOR; DIAGNOSTIC USE; IMAGE ENHANCEMENT; MAMMOGRAPHY; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PROCEDURES;

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84903690825     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2014.05.006     Document Type: Article

References (28)

1. G. Liney MRI from A to Z. A definitive guide for medical professionals 2010 Springer-Verlag London, New York
2. B. Alicoglu, O. Guler, and N. Bulakbasi et al. Utility of semiquantitative parameters to differentiate benign and malignant focal hepatic lesions Clin Imaging 2013 10.1016/j.clinimag.01.012
3. S. Vignot, J. Spano, and R. Bloch et al. CT perfusion as index of activity of antiangiogenic treatment of metastatic carcinoma [abstract] J Clin Oncol, ASCO Annual Meeting Proceedings 26 15S 2008 3548
4. A. Khiat, D. Gianfelice, and M. Amara et al. Influence of post-treatment delay on the evaluation of the response to focused ultrasound surgery of breast cancer by dynamic contrast enhanced MRI Br Journal Radiol 79 2006 308 314
5. H. Meyer Improving breast MR diagnosis using a new postprocessing package and MR guided biopsies [abstract] Third international congress on MR-mammography 25-27 September 2003, Jena, Germany Eur Radiol 13 2003 D44 D46
6. P. Lamby, L. Pranti, and C. Fellner et al. Post-operative monitoring of tissue transfers: advantages using contrast enhanced ultrasound (CEUS) and contrast enhanced MRI (ceMRI) with dynamic perfusion analysis Clin Hemorheol Microcirc 489 2011 105 117
7. L. Fan, Y. Xia, and Y. Guan et al. Capability of differentiating smokers with normal pulmonary function from COPD patients: a comparison of CT pulmonary volume analysis and MR perfusion imaging Eur Radiol 23 2012 1234 1241
8. S. Guan, W.D. Zhao, and K.R. Zhou et al. Assessment of hemodynamics in precancerous lesion of hepatocellular carcinoma: evaluation with MR perfusion World J Gastroenterol 13 2007 1182 1186
9. H. Yang, D. Yu, and X. Ma et al. Role of quantitative parameters of dynamic contrast-enhanced MRI at 3.0 Tesla in differential diagnosis of hepatic masses J Shandong Univ (Health Sciences) 48 2010 139 142
10. A. Bane Ductal carcinoma in situ: what the pathologist needs to know and why Int J Breast Cancer 2013 914053
11. B.A. Viring, T. Shamilyan, and T.M. Tuttle et al. Diagnosis and management of ductal carcinoma in situ (DCIS) Evid Rep Technol Assess 185 2009 1 549
12. A. Padhani Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions J Magn Reson Imaging 16 2002 407 422
13. T. Yamada, N. Mori, and M. Watanabe et al. Radiologic-pathologic correlation of ductal carcinoma in situ Radiographics 30 2010 1183 1198
14. A.J. Guidi, L. Fischer, and J.R. Harris et al. Micro-vessel density and distribution in ductal carcinoma in situ of the breast J Natl Cancer Inst 86 1994 614 619
15. C.K. Kuhl, S. Schrading, and H.H. Bieling et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study Lancet 370 2007 485 492
16. C.K. Kuhl Science to practice: why do purely intraductal cancers enhance on breast MR images Radiology 253 2009 281 283
17. C.J. D'Orsi, E.B. Mendelson, and D.M. Ikeda et al. ACR Breast imaging reporting and data system: ACR BI-RADS - Breast Imaging Atlas 2003 American College of Radiology Reston, VA
18. E.E. Deurloo, J.D. Sriram, and H.J. Teertstra et al. MRI of the breast in patients with DCIS to exclude the presence of invasive disease Eur Radiol 22 2012 1504 1511
19. S. Glaßer, S. Schäfer, and S. Oeltze et al. A visual analytics approach to diagnosis of breast DCE-MRI data Proc. of Vision, Modeling, and Visualization (VMV) Braunschweig 2009
20. R. Tello, and P.E. Crewson Hypothesis Testing II: Means Radiology 227 2003 1 4
21. S. Raza, M. Vallejo, and S.A. Chikarmane et al. Pure ductal carcinoma in situ: a range of MRI features AJR 191 2008 689 699
22. K. Oshida, T. Nagashima, and T. Ueda et al. Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography Eur Radiol 15 2005 1353 1360
23. G. Gasparini, and A.L. Harris Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool J Clin Oncol 13 1995 765 782
24. H. Hirasawa, Y. Tsushima, and S. Hirasawa et al. Perfusion CT of breast carcinoma: arterial perfusion of nonscirrhous carcinoma was higher than that of scirrhous carcinoma Acad Radiol 14 2007 547 552
25. S. Buchbender, S. Obenauer, and S. Mohrmann et al. Arterial spin labeling perfusion MRI of breast cancer using FAIR TrueFISP: initial results Clin Radiol 68 2013 e123 e127
26. X. Zhuang, B. Zhang, and B. Zhu et al. Application of T2*-weighted first-pass perfusion imaging in the diagnosis of breast tumors Chinese-German J Clin Oncol 6 2007 357 360
27. E.A.M. O'Flynn, and N.M. deSouza Functional magnetic resonance: biomarkers of response in breast cancer Breast Cancer Res 13 2013 204
28. A. Padhani Science to practice: what does MR oxygenation imaging tell us about human breast cancer hypoxia Radiology 254 2010 1 3